Healthcare Realty Trust Inc
HRDrugs in Pipeline
12
Phase 3 Programs
9
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
[18F] Flutemetamol
Brain Fibrillarab Levels
123I-mIBG (meta-iodobenzylguanidine)
Pheochromocytoma
MBK-01
Diverticulitis
Gadodiamide Injection
Renal Artery Stenosis
Ibuprofen 200Mg Oral Cap
Tooth, Impacted
Compound Sodium Alginate Double Action Chewable Tablets
Gastroesophageal Reflux Disease
Nicotine Spray
Tobacco Dependence
Acetaminophen
Pain
Fidaxomicin
Recurrent Clostridium Difficile Infection
Dose Escalation
Advanced Malignant Solid Tumors
JNJ-10450232 / Not yet marketed
Pain
Acetaminophen ER
Dental Pain
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
[18F] Flutemetamol | Phase 3 | Brain Fibrillarab Levels | - | - |
123I-mIBG (meta-iodobenzylguanidine) | Phase 3 | Pheochromocytoma | - | - |
MBK-01 | Phase 3 | Diverticulitis | - | - |
Gadodiamide Injection | Phase 3 | Renal Artery Stenosis | - | - |
Ibuprofen 200Mg Oral Cap | Phase 3 | Tooth, Impacted | - | - |
Compound Sodium Alginate Double Action Chewable Tablets | Phase 3 | Gastroesophageal Reflux Disease | - | - |
Nicotine Spray | Phase 3 | Tobacco Dependence | - | - |
Acetaminophen | Phase 3 | Pain | - | - |
Fidaxomicin | Phase 3 | Recurrent Clostridium Difficile Infection | - | - |
Dose Escalation | Phase 2 | Advanced Malignant Solid Tumors | - | - |
JNJ-10450232 / Not yet marketed | Phase 2 | Pain | - | - |
Acetaminophen ER | Phase 2 | Dental Pain | - | - |